Results 91 to 100 of about 48,174 (231)
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
British Journal of Clinical Pharmacology, EarlyView.Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
QALY: Quality Adjusted Life Year
Medicine Science, 2012 Nufusun yaslanmasi ve yaslilik donemi hastaliklar ile kronik hastaliklarin one cikmasi verilen saglik hizmetlerinin sadece saglik duzeyi uzerine degil yasam kalitesine etkisinin de onemli bir cikti olarak degerlendirilmesini getirmistir.
Selale Sahin, Selime Toprak, Erdinc Unal
doaj +1 more source
Efficient use of health care resources: The interaction between improved health and reduced health related income loss [PDF]
Cost effectiveness is a criterion that is often recommended for prioritizing between different types of health care. A modified use of this criterion can be justified as the outcome of a choice that is made “behind a veil of ignorance”.
Hoel, Michael
core
COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES
Фармакоэкономика, 2015 a total of 62 patients with a diagnosis of low back pain. Low back pain patients were randomized of two group. Patients of the first (main) group received a course of intraosseous blockades, while patients of the second (control group) received a course ...
M. V. Yakovlev +3 more
doaj
Health Technology AssessmentBackground Renal cell carcinoma is the most common type of kidney cancer, comprising approximately 85% of all renal malignancies. Patients with advanced renal cell carcinoma are the focus of this National Institute for Health and Care Excellence multiple
Nigel Fleeman +13 more
doaj +1 more source
QALY-based cost-effectiveness acceptability curves (societal perspective).
, 2012 QALY-based cost-effectiveness acceptability curves (societal perspective).
Anthony L. Johnson (124576) +6 more
core +1 more source
Фармакоэкономика, 2015 The analysis goal is to determine the cost-effectiveness of liraglutideas add-on to metformin in for patients with type 2 diabetes in condition of the Russian health care system.
A. Yu. Kulikov, I. V. Novikov
doaj
Value in Health, 2009 In the preceding article, Weinstein et al. [1] explain the QALYconcept, its methods, and their underlying assumptions. Anumber of interesting themes for discussion arise from thisfactual presentation. We restrict ourselves to addressing fourissues that we deem particularly challenging.As a general background for our selection of issues, we reit-erate a
Nord, Erik +2 more
openaire +2 more sources
Determining risk preferences for pain [PDF]
The QALY concept is the commonly used approach in research to evaluate the efficiency of therapies in cost utility analysis. We investigate the risk neutrality assumption for time of the QALY concept: can time be included as a linear factor?
Bodo Vogt +2 more
core